
AbstractDespite recent progress in the understanding of γδ T cells’ roles and functions, their interaction with αβ T cells still remains to be elucidated. In this study, we sought to clarify what precisely endows peripheral Vδ2+T cells with immunosuppressive function on autologous αβ T cells. We found that negatively freshly isolated Vδ2+T cells do not exhibit suppressive behavior, even after stimulation with IL-12/IL-18/IL-15 or the sheer contact with butyrophilin-3A1-expressing tumor cell lines (U251 or SK-Mel-28). On the other hand, Vδ2+T cells positively isolated through TCR crosslinking or after prolonged stimulation with isopentenyl pyrophosphate (IPP) mediate strong inhibitory effects on αβ T cell proliferation. Stimulation with IPP in the presence of IL-15 induces the most robust suppressive phenotype of Vδ2+T cells. This indicates that Vδ2+T cells’ suppressive activity is dependent on a TCR signal and that the degree of suppression correlates with its strength. Vδ2+T cell immunosuppression does not correlate with their Foxp3 expression but rather with their PD-L1 protein expression, evidenced by the massive reduction of suppressive activity when using a blocking antibody. In conclusion, pharmacologic stimulation of Vδ2+T cells via the Vδ2 TCR for activation and expansion induces Vδ2+T cells' potent killer activity while simultaneously licensing them to suppress αβ T cell responses. Taken together, the study is a further step to understand—in more detail—the suppressive activity of Vδ2+γδ T cells.
Interleukin-15, Receptors, Antigen, T-Cell, Gene Expression, Apoptosis, Receptors, Antigen, T-Cell, gamma-delta, Lymphocyte Activation, B7-H1 Antigen, Hemiterpenes, Organophosphorus Compounds, T-Lymphocyte Subsets, Cell Line, Tumor, Apoptosis/immunology [MeSH] ; Cell Line, Tumor [MeSH] ; TCR signal strength ; T-Lymphocyte Subsets/immunology [MeSH] ; Gene Expression/drug effects [MeSH] ; B7-H1 Antigen/metabolism [MeSH] ; γδ T cells ; Lymphocyte Activation/drug effects [MeSH] ; Original Article ; T-Lymphocyte Subsets/metabolism [MeSH] ; Gene Expression/immunology [MeSH] ; Signal Transduction/drug effects [MeSH] ; Immune Tolerance/immunology [MeSH] ; B7-H1 Antigen/genetics [MeSH] ; Immune Tolerance/drug effects [MeSH] ; T-Lymphocyte Subsets/drug effects [MeSH] ; Interleukin-15/pharmacology [MeSH] ; IPP ; Receptors, Antigen, T-Cell, gamma-delta/immunology [MeSH] ; B7-H1 Antigen/immunology [MeSH] ; Receptors, Antigen, T-Cell/metabolism [MeSH] ; Lymphocyte Activation/immunology [MeSH] ; Humans [MeSH] ; Apoptosis/drug effects [MeSH] ; Immune Tolerance/genetics [MeSH] ; Immunosuppression ; Receptors, Antigen, T-Cell/immunology [MeSH] ; Signal Transduction/immunology [MeSH] ; Organophosphorus Compounds/pharmacology [MeSH] ; TCR-induced immune suppression ; Receptors, Antigen, T-Cell, gamma-delta/metabolism [MeSH] ; Cells, Cultured [MeSH] ; Hemiterpenes/pharmacology [MeSH] ; Cell Proliferation/drug effects [MeSH], Immune Tolerance, Humans, Original Article, Cells, Cultured, Cell Proliferation, Signal Transduction
Interleukin-15, Receptors, Antigen, T-Cell, Gene Expression, Apoptosis, Receptors, Antigen, T-Cell, gamma-delta, Lymphocyte Activation, B7-H1 Antigen, Hemiterpenes, Organophosphorus Compounds, T-Lymphocyte Subsets, Cell Line, Tumor, Apoptosis/immunology [MeSH] ; Cell Line, Tumor [MeSH] ; TCR signal strength ; T-Lymphocyte Subsets/immunology [MeSH] ; Gene Expression/drug effects [MeSH] ; B7-H1 Antigen/metabolism [MeSH] ; γδ T cells ; Lymphocyte Activation/drug effects [MeSH] ; Original Article ; T-Lymphocyte Subsets/metabolism [MeSH] ; Gene Expression/immunology [MeSH] ; Signal Transduction/drug effects [MeSH] ; Immune Tolerance/immunology [MeSH] ; B7-H1 Antigen/genetics [MeSH] ; Immune Tolerance/drug effects [MeSH] ; T-Lymphocyte Subsets/drug effects [MeSH] ; Interleukin-15/pharmacology [MeSH] ; IPP ; Receptors, Antigen, T-Cell, gamma-delta/immunology [MeSH] ; B7-H1 Antigen/immunology [MeSH] ; Receptors, Antigen, T-Cell/metabolism [MeSH] ; Lymphocyte Activation/immunology [MeSH] ; Humans [MeSH] ; Apoptosis/drug effects [MeSH] ; Immune Tolerance/genetics [MeSH] ; Immunosuppression ; Receptors, Antigen, T-Cell/immunology [MeSH] ; Signal Transduction/immunology [MeSH] ; Organophosphorus Compounds/pharmacology [MeSH] ; TCR-induced immune suppression ; Receptors, Antigen, T-Cell, gamma-delta/metabolism [MeSH] ; Cells, Cultured [MeSH] ; Hemiterpenes/pharmacology [MeSH] ; Cell Proliferation/drug effects [MeSH], Immune Tolerance, Humans, Original Article, Cells, Cultured, Cell Proliferation, Signal Transduction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 19 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
